Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

SARS-CoV-2 vaccine

SARS-CoV-2 vaccine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
COMIRNATY/Pfizer SUSPENSION, INTRAMUSCULAR 0.3 mL      
Spikevax/Moderna SUSPENSION, INTRAMUSCULAR 0.3 mL      
Novavax COVID-19 Vaccine, Adjuvanted PF SUSPENSION, INTRAMUSCULAR 0.5 mL      


Comments:

2023: Updated Omicron XBB.1.5-adapted monovalent COVID-19 vaccines were reviewed. Both mRNA vaccines, from Pfizer and Moderna, were approved for use. These two vaccines will be classified as interchangeable and the most cost-effective product will be utilized in both inpatient and outpatient settings.

 

 

To be used per FDA-approved indications, Emergency Use Authorizations (EUA), and CDC guidelines.

NOTE: As of January 31, 2022, Huntsville Hospital will no longer offer the COVID-19 vaccines to inpatients, ED patients, or patients in the behavioral health units. Huntsville Hospital will continue to offer Pfizer COVID-19 vaccines to employees via employee health and to the general public by appointment at the Fever and Flu Clinic. The Moderna COVID-19 vaccine is available at the Huntsville Hospital Med Mall Pharmacy.

 


Reviewed: December 2020 , February 2021 (Ad26.COV.S), Dec. 2022 (Novavax)

Updated: May 2021 (BNT162b2-pediatrics), September 2021 (BNT162b2, EUA update), Sept. 2022, September 2023 (Omicron-monovalent, Novavax)


Last updated: Oct. 11, 2023







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.